Russell H. Glantz

574 total citations
19 papers, 424 citations indexed

About

Russell H. Glantz is a scholar working on Neurology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Russell H. Glantz has authored 19 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 6 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Russell H. Glantz's work include Neurological disorders and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). Russell H. Glantz is often cited by papers focused on Neurological disorders and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). Russell H. Glantz collaborates with scholars based in United States. Russell H. Glantz's co-authors include Harold L. Klawans, Christopher G. Goetz, Caroline M. Tanner, William J. Weiner, Paul A. Nausieda, Irwin M. Siegel, David C. Garron, Lois Margaret Nora, Michael S. Huckman and Linas A. Bieliauskas and has published in prestigious journals such as Neurology, Annals of Neurology and Journal of Consulting and Clinical Psychology.

In The Last Decade

Russell H. Glantz

19 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Russell H. Glantz United States 12 307 158 68 59 52 19 424
I.M. Donaldson New Zealand 13 174 0.6× 163 1.0× 71 1.0× 71 1.2× 71 1.4× 32 516
G. Defer France 8 261 0.9× 101 0.6× 37 0.5× 26 0.4× 76 1.5× 20 377
Gudni Thorsteinsson United States 7 200 0.7× 78 0.5× 31 0.5× 24 0.4× 51 1.0× 12 449
Marie-Hélène Marion United Kingdom 11 541 1.8× 215 1.4× 45 0.7× 41 0.7× 61 1.2× 22 624
C. Ohye Japan 16 471 1.5× 299 1.9× 25 0.4× 36 0.6× 109 2.1× 39 661
Annemarie Vlaar Netherlands 15 510 1.7× 200 1.3× 62 0.9× 84 1.4× 82 1.6× 26 728
S Brion France 12 190 0.6× 161 1.0× 98 1.4× 74 1.3× 149 2.9× 59 540
Joseph Jankovic United States 11 428 1.4× 259 1.6× 40 0.6× 71 1.2× 134 2.6× 17 673
N. Canal Italy 11 215 0.7× 97 0.6× 78 1.1× 60 1.0× 35 0.7× 30 551
R. D'Antona Italy 8 217 0.7× 136 0.9× 59 0.9× 114 1.9× 168 3.2× 9 560

Countries citing papers authored by Russell H. Glantz

Since Specialization
Citations

This map shows the geographic impact of Russell H. Glantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell H. Glantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell H. Glantz more than expected).

Fields of papers citing papers by Russell H. Glantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell H. Glantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell H. Glantz. The network helps show where Russell H. Glantz may publish in the future.

Co-authorship network of co-authors of Russell H. Glantz

This figure shows the co-authorship network connecting the top 25 collaborators of Russell H. Glantz. A scholar is included among the top collaborators of Russell H. Glantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell H. Glantz. Russell H. Glantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Glantz, Russell H., et al.. (1993). Respiratory Dyskinesia Presenting as Acute Respiratory Distress. CHEST Journal. 103(1). 314–316. 5 indexed citations
2.
Bieliauskas, Linas A. & Russell H. Glantz. (1989). Depression type in Parkinson Disease. Journal of clinical and experimental neuropsychology. 11(5). 597–604. 23 indexed citations
3.
Glantz, Russell H., et al.. (1988). Hearing loss in myotonic dystrophy. Annals of Neurology. 23(2). 202–203. 16 indexed citations
4.
Glantz, Russell H., et al.. (1988). Central Nervous System Magnetic Resonance Imaging Findings in Myotonic Dystrophy. Archives of Neurology. 45(1). 36–37. 71 indexed citations
5.
Siegel, Irwin M. & Russell H. Glantz. (1988). Clinical Management Review: Orthopedic Rehabilitation for Standing and Walking in Selected Neuromuscular Diseases. Neurorehabilitation and neural repair. 2(3). 131–136. 1 indexed citations
6.
Bieliauskas, Linas A. & Russell H. Glantz. (1987). Use of the Mini-Mult D scale in patients with Parkinson's disease.. Journal of Consulting and Clinical Psychology. 55(3). 437–438. 1 indexed citations
7.
Bieliauskas, Linas A. & Russell H. Glantz. (1987). Use of the Mini-Mult D scale in patients with Parkinson's disease.. Journal of Consulting and Clinical Psychology. 55(3). 437–438. 3 indexed citations
8.
Goetz, Christopher G., Caroline M. Tanner, Russell H. Glantz, & Harold L. Klawans. (1985). Chronic agonist therapy for Parkinson's disease. Neurology. 35(5). 749–749. 60 indexed citations
9.
Siegel, Irwin M., Brenda R. Eisenberg, & Russell H. Glantz. (1984). Contributory Etiologic Factor for Talipes Equinovarus in Congenital Myotonic Dystrophy. Journal of Pediatric Orthopaedics. 4(3). 327–330. 6 indexed citations
10.
Nausieda, Paul A., Russell H. Glantz, Sandrina Weber, Rebecca Baum, & Harold L. Klawans. (1984). Psychiatric complications of levodopa therapy of Parkinson's disease.. PubMed. 40. 271–7. 44 indexed citations
11.
Weiner, William J., Lois Margaret Nora, & Russell H. Glantz. (1984). Elderly inpatients. Neurology. 34(7). 945–945. 41 indexed citations
12.
Goetz, Christopher G., Caroline M. Tanner, Russell H. Glantz, & H. L. Klawans. (1983). Pergolide in Parkinson's Disease. Archives of Neurology. 40(13). 785–787. 15 indexed citations
13.
Tanner, Caroline M., et al.. (1983). Pharmacology of cranial dystonia. Neurology. 33(8). 1101–1101. 3 indexed citations
14.
Glantz, Russell H., W.J. Werner, Christopher G. Goetz, Paul A. Nausieda, & Harold L. Klawans. (1982). Drug‐induced asterixis in Parkinson disease. Neurology. 32(5). 553–553. 13 indexed citations
15.
Tanner, Caroline M., Christopher G. Goetz, Russell H. Glantz, Sander L. Glatt, & Harold L. Klawans. (1982). Pergolide mesylate and idiopathic Parkinson disease. Neurology. 32(10). 1175–1175. 27 indexed citations
16.
Klawans, Harold L., Russell H. Glantz, Caroline M. Tanner, & Christopher G. Goetz. (1982). Primary writing tremor. Neurology. 32(2). 203–203. 33 indexed citations
17.
Tanner, Caroline M., Russell H. Glantz, & Harold L. Klawans. (1982). Meige disease. Neurology. 32(7). 783–783. 23 indexed citations
18.
Weiner, William J., Paul A. Nausieda, & Russell H. Glantz. (1981). Meige syndrome (blepharospasm‐oromandibular dystonia) after long‐term neuroleptic therapy. Neurology. 31(12). 1555–1555. 32 indexed citations
19.
Glantz, Russell H., Christopher G. Goetz, Paul A. Nausieda, William J. Weiner, & Harold L. Klawans. (1981). The effect of bromocriptine (BCT) on the on-off phenomenon. Journal of Neural Transmission. 52(1-2). 41–47. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026